The European meeting on helicobacter pylori: Therapeutic news from lisbon

Gut

Volumn 43, Issue SUPPL. 1, 1998, Pages

  Peitz, U ^a   Menegatti, M ^b   Vaira, D ^b   Malfertheiner, P ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLARITHROMYCIN; LANSOPRAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG MIXTURE; DUODENUM ULCER; DYSPEPSIA; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL;

EID: 0031871485     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.2008.s66     Document Type: Conference Paper

References (24)

1. Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxicillin, and metronidazole compared with four alternative regimens. Q J Med 1993;86:743-50.
2. Bazzoli F, Zagari RM, Fossi S, et al. Short term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
3. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
4. Lind T, Mégraud F, Bardhan K, et al. The MACH2 study: antimicrobial resistance in Helicobacter pylori therapy: the impact of omeprazole [abstract]. Gut 1997;41(suppl 1):A89.
5. Ruszniewski P, Lamouliatte H, Flejou JF, et al. Evaluation of short-term ranitidine vs omeprazole triple therapy regimens for eradication of Helicobacter pylori in duodenal ulcer patients [abstract]. Gut 1997;41(suppl 1):A94.
6. Malfertheiner P, Bayerdorffer E, Diete U, et al. The GU-Mach study: eradication of Helicobacter pylori, ulcer healing and relapse in gastric ulcer patients. Omeprazole and clarithromycin in combination with either amoxicillin or metronidazole [abstract]. Gut 1997;41(suppl 1):A97.
7. Veldhuzen van Zanten SJO, Bradette M, Parley A, et al. The DU-mach study: eradication of Helicobacter pylori, ulcer healing and relapse in duodenal ulcer patients. Omeprazole and clarithromycin in combination with either amoxicillin or metronidazole [abstract]. Gut 1997;41(suppl 1):A103.
8. Treiber G, Ammon S, Schneider. AMOC: a short new quadruple therapy vs standard triple therapy for Helicobacter pylori eradication [abstract]. Gut 1997;41(suppl 1):A96.
9. Gisbert JP, Boixeda D, de Rafael L, et al. Efficacy on H. pylori eradication and duodenal ulcer healing with one-week twice-daily triple therapies [abstract]. Gut 1997;41(suppl 1):A95.
10. Yang JC, Shun CT, Yang CK. A multicenter study of lansoprazole combined with antibiotics to eradicate Helicobacter pylori infection in the patients with duodenal ulcer [abstract]. Gut 1997;41(suppl 1):A99.
11. Spadaccini A, De Fanis C, Sciampa G, et al. Lansoprazole or ranitidine bismuth citrate based triple therapies for Helico-bacter pylori eradication: results of an open randomized study [abstract]. Gut 1997;41(suppl 1):A105.
12. Damman HG, Folsch UR Hahn EG, et al. 7 vs 14 days treatment with pantoprazole, clarithromycin and metronidazole for cure of H. pylori infection in duodenal ulcer patients [abstract]. Gut 1997;41(suppl 1):A95.
13. Frevel M, Daake H, Janisch HD, et al. Pantotrazole plus clarithromycin and metronidazole versus pantoprazole plus clarithromycin and amoxycillin for therapy of H. pylori infection [abstract]. Gut 1997;41(suppl 1):A103
14. Gudjonsson H, Bardhan KD, Hoie O, et al. High H. pylori eradication rate with a one-week triple regimen containing ranitidine bismuth citrate (RBC) [abstract]. Gut 1997;41:A99.
15. Adamek RJ, Pfaffenbach B. Szymanski C. Does pretreatment with pantoprazole affect the efficacy of a modern triple therapy in HP cure? [abstract] Gut 1997;41:A95
16. Katicic M, Presecki V, Marusic M, el al. Eradication of H. pylori infection with two triple-therapy regimes of 7, 10 and 14 days duration [abstract]. Gut 1997;41(suppl 1):A100.
17. Huelin Benita J, Jimenez Perez M, Sanchez Galdon S, et al. Short-course treatment to eradicate H. pylori in 246 patients with peptic ulcer disease [abstract]. Gut 1997;41(suppl 1):A105.
18. Chen CY, Sheu MZ, Lee SC. Intravenous dual therapy and oral new triple therapy in Helicobacter-related ulcer bleeding with major stigmas of recent hemorrhage [abstract]. Gut 1997;41(suppl 1):A98.
19. Pieramico O, Zanetti MV, Innerhofer M. Outcome of omeprazole-based dual and triple therapy for Helicobacter pylori eradication: do gastroduodenal disease and age play a role? [abstract] Gut 1997;41(suppl 1):A91.
20. Buda A, Dal Bo N, Kusstatscher S, et al. Different lansoprazole dosages in H. pylori eradication therapy: a prospective multicenter randomised study comparing 30 mg b.i.d. vs 15 mg b.i.d. [abstract]. Gut 1997;41(suppl 1):A92.
21. Lamouliatte H, The Aquitaine-Gastro Association, de Mascarel A, et al. Double-blind study comparing once daily versus twice daily dosage of PPI with amoxicillin-clarithromycin for H. pylori cure [abstract]. Gut 1997;41(suppl 1):A93.
22. Laine L, Estrada R, Trujillo M, et al. Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H. pylori [abstract]. Gut 1997;41:A103
23. Schütze K, Hentschel E, Hirschl AM. Duodenal ulcer healing after 7-day treatment with amoxicillin, metronidazole and omeprazole (20 vs 40 mg) without acid suppression [abstract]. Gut 1997;41(suppl 1):A98.
24. Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study. Helicobacter 1996;1:138-44.